Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up studyJames O. Lindsay, Richard Emsley, Laura Mandefield et al.|BMC Gastroenterology|2019Cited by 30
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O. Lindsay, John A. Snowden, Daniel Hind et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 19
Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCTJames O. Lindsay, John A. Snowden, Daniel Hind et al.|Efficacy and Mechanism Evaluation|2024Cited by 1